We are excited to announce the inauguration of AFRIPHAR, our state-of-the-art pharmaceutical manufacturing facility in the Democratic Republic of Congo (DRC). This milestone facility, equipped with cutting-edge technology, sets new standards for quality and precision in pharmaceutical production. AFRIPHAR is dedicated to delivering high-quality medicines, strengthening the local healthcare system, and enhancing accessibility to essential treatments. By reducing dependency on imports and fostering local production, it supports the country’s journey towards self-sufficiency and economic growth. This marks a significant advancement in pharmaceutical innovation in DRC, reinforcing our commitment to a healthier future for all.